| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Nutrien Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$52.57 |
| 52 Week High | CA$71.02 |
| 52 Week Low | CA$48.00 |
| Beta | 0.97 |
| 1 Month Change | -2.17% |
| 3 Month Change | 3.52% |
| 1 Year Change | -25.48% |
| 3 Year Change | -0.067% |
| 5 Year Change | -0.70% |
| Change since IPO | -3.09% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0NHS | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | -0.7% | -0.1% | -0.7% |
| 1Y | -25.5% | -37.0% | -1.8% |
Return vs Industry: 0NHS exceeded the UK Chemicals industry which returned -37% over the past year.
Return vs Market: 0NHS underperformed the UK Market which returned -1.8% over the past year.
Price Volatility
| 0NHS volatility | |
|---|---|
| 0NHS Average Weekly Movement | 3.9% |
| Chemicals Industry Average Movement | 6.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0NHS has not had significant price volatility in the past 3 months.
Volatility Over Time: 0NHS's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 25,900 | Ken Seitz | www.nutrien.com |
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products.
Nutrien Ltd. Fundamentals Summary
| 0NHS fundamental statistics | |
|---|---|
| Market cap | US$26.03b |
| Earnings (TTM) | US$1.26b |
| Revenue (TTM) | US$28.08b |
20.7x
P/E Ratio0.9x
P/S RatioIs 0NHS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0NHS income statement (TTM) | |
|---|---|
| Revenue | US$28.08b |
| Cost of Revenue | US$19.61b |
| Gross Profit | US$8.47b |
| Other Expenses | US$7.22b |
| Earnings | US$1.26b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 08, 2024
| Earnings per share (EPS) | 2.54 |
| Gross Margin | 30.18% |
| Net Profit Margin | 4.48% |
| Debt/Equity Ratio | 44.6% |
How did 0NHS perform over the long term?
See historical performance and comparison